Kamada Ltd
KMDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567529
In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Kamada Ltd changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 23 | 23 | 0 |
| Shares | 6.05M | 5.92M | −125.5K (−2.1%) |
| Value | $28.1M | $31.0M | +$2.89M (+10.3%) |
New holders (4)
Institutions that held Kamada Ltd at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JPMorgan Chase & Co | 15,826 | $83.5K | 0.00% |
| Bank of Montreal | 49,391 | $70.2K | 0.00% |
| State of Tennessee, Treasury Department | 7,147 | $37.6K | 0.00% |
| Bank of America Corp | 5,181 | $27.3K | 0.00% |
Sold out (4)
Institutions that held Kamada Ltd at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| UBS Group AG | 47,783 | $222.0K |
| Ergoteles LLC | 25,398 | $117.6K |
| Mariner, LLC | 14,325 | $67.0K |
| Belpointe Asset Management LLC | 2,000 | $9.29K |